MedTrace Logo

ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation

NCT05009550 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-08-17

No results posted yet for this study

Summary

To evaluate the ability of Erector spina Plane Block decrease postoperative pain and analgesia requirements in patients undergoing percutaneous Radiofrequency ablation of Hepatocellular Carcinomas.

Conditions

  • Hepatic Carcinoma

Interventions

PROCEDURE

Group ESP

Single-shot ultrasound guided ESP block is performed at the T8 vertebral level before the procedure to all patients in ESP block Group

OTHER

Non-blocked Group

This Group is received no intervention.Patients will be sedated as standard and radiofrequency procedure will be applied.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Ozlem Oz Gergin, MD · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05009550 on ClinicalTrials.gov